Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2019-08-10 2019-08-09
Drug Identification Number 02423979 02423979
Brand name RAN-ESOMEPRAZOLE RAN-ESOMEPRAZOLE
Common or Proper name RAN-ESOMEPRAZOLE RAN-ESOMEPRAZOLE
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients ESOMEPRAZOLE ESOMEPRAZOLE
Strength(s) 20MG 20MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-08-09 2019-08-09
Remaining supply date 2019-08-09 2019-08-09
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Bottle of 30 only. Other sizes available. Bottle of 30 only. Other sizes available.
Health Canada comments